Status:
COMPLETED
Renal Nerve Ablation in Chronic Kidney Disease Patients
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Hypertension
Chronic Kidney Disease
Eligibility:
All Genders
18-85 years
Brief Summary
In patients with treatment resistent hypertension renal nerve ablation emerged as an effective interventional approach of treating hypertensive disease with a progressively increasing fall in blood pr...
Detailed Description
In patients with treatment resistent hypertension renal nerve ablation emerged as an effective interventional approach of treating hypertensive disease with a progressively increasing fall in blood pr...
Eligibility Criteria
Inclusion
- treatment resistant hypertension
- chronic kidney disease 3 - 5
- male of female aged over 18 years
- written informed consent
- agreement to attend all study visits as planned in the protocol
Exclusion
- any contraindications for MRI
- claustrophobia
- strabismus
- severe ocular diseases
- history of epilepsia
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01442883
Start Date
November 1 2010
End Date
June 1 2019
Last Update
March 26 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg
Erlangen, Germany, 91054
2
Joachim Weil
Lübeck, Germany